IJGC

Risk of second malignancy in patients with ovarian clear cell carcinoma
Julie My Van Nguyen, Danielle Vicus, Sharon Nofech-Mozes, Lilian T Gien, Marcus Q Bernardini, Marjan Rouzbahman, Liat Hogen

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 545-552; DOI: 10.1136/ijgc-2020-001946
Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study
Tamara Jones, Carolina Sandler, Dimitrios Vagenas, Monika Janda, Andreas Obermair, Sandra Hayes

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 553-561; DOI: 10.1136/ijgc-2020-002107
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission
Oren Smaletz, Gustavo Ismael, Maria Del Pilar Estevez-Diz, Ivana L O Nascimento, Ana Luiza Gomes de Morais, Geraldo Felício Cunha-Junior, Sergio J Azevedo, Venancio A Alves, Ana Maria Moro, Fernanda P Yeda, Mariana Lopes dos Santos, Indrani Majumder, Eric W Hoffman

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 562-568; DOI: 10.1136/ijgc-2020-002239
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M de Boer, Tjalling Bosse, Carien L Creutzberg

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 594-604; DOI: 10.1136/ijgc-2020-001822
Clear cell carcinoma of the ovary: a clinical and molecular perspective
Yasushi Iida, Aikou Okamoto, Robert L Hollis, Charlie Gourley, C Simon Herrington

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 605-616; DOI: 10.1136/ijgc-2020-001656
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Antonio Gonzalez Martin, Luisa Sanchez Lorenzo, Nicoletta Colombo, René dePont Christensen, Florian Heitz, Mihai Meirovitz, Frederic Selle, Toon van Gorp, Nuria Alvarez, Javier Sanchez, Carmen Marqués

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 617-622; DOI: 10.1136/ijgc-2020-001633
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
Akiko Furusawa, Munetaka Takekuma, Keita Mori, Tomoka Usami, Eiji Kondo, Shin Nishio, Koji Nishino, Yuichiro Miyamoto, Ryoichi Yoshimura, Miho Watanabe, Mikio Mikami, Takayuki Enomoto

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 623-626; DOI: 10.1136/ijgc-2020-002344
Recurrence of vulvar squamous cell carcinoma as an undifferentiated sarcomatoid carcinoma
Chiara Comerio, Marta Jaconi, Benedetta Zambetti, Mariachiara Paderno, Maria Gabriella Valente, Alessandro Buda

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 627-630; DOI: 10.1136/ijgc-2020-002193
An update on cervical cancer screening in Vanuatu
Emma R Allanson, Vera Velanova, Ian H Frazer, Margaret McAdam

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 631-632; DOI: 10.1136/ijgc-2020-002129
Laparoscopic radical pelvic dissection for safely removing a large cervical myoma
Mo Chen, Jiajia Li, Xiaojun Yin, Liangqing Yao

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 633-634; DOI: 10.1136/ijgc-2020-001507

Main menu

IJGC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

IJGC

Pages